Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. INDP
stocks logo

INDP

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
--
--
-4.360
-59.02%
--
--
-1.870
-79.13%
--
--
-1.570
-82.73%
Estimates Revision
The market is revising No Change the revenue expectations for Indaptus Therapeutics, Inc. (INDP) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -35.21%.
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-35.21%
In Past 3 Month
Wall Street analysts forecast INDP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INDP is 10.00 USD with a low forecast of 10.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast INDP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INDP is 10.00 USD with a low forecast of 10.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.140
sliders
Low
10.00
Averages
10.00
High
10.00
Current: 2.140
sliders
Low
10.00
Averages
10.00
High
10.00
no data image
No Data

Valuation Metrics

The current forward P/E ratio for Indaptus Therapeutics Inc (INDP.O) is -0.23, compared to its 5-year average forward P/E of -1.14. For a more detailed relative valuation and DCF analysis to assess Indaptus Therapeutics Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.14
Current PE
-0.23
Overvalued PE
-0.47
Undervalued PE
-1.81

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

INDP News & Events

Events Timeline

(ET)
2025-11-12
08:33:38
Indaptus Therapeutics announces Q3 EPS of $2.98 compared to a loss of $9.04 in the previous year.
select
2025-09-04 (ET)
2025-09-04
16:04:48
Indaptus Therapeutics Shares Progress on INDP-D101 Clinical Trial
select
2025-09-02 (ET)
2025-09-02
09:18:18
Indaptus Therapeutics seeks approval to offer 781,250 shares of common stock and warrants.
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
2.0
06-25Newsfilter
Indaptus Therapeutics Announces Reverse Stock Split

  • Reverse Stock Split Announcement: Indaptus Therapeutics has approved a one-for-twenty-eight reverse stock split of its common stock, effective after trading on June 26, 2025, to comply with Nasdaq listing requirements and attract institutional investors.

  • Impact on Shares: Following the split, approximately 16 million outstanding shares will be reduced to about 572 thousand, with adjustments made to options and warrants; fractional shares will be compensated in cash.

[object Object]
Preview
7.0
06-25NASDAQ.COM
Indaptus Therapeutics Sets 1-for-28 Reverse Stock Split

  • Reverse Stock Split Announcement: Indaptus Therapeutics, Inc. has approved a one-for-twenty-eight reverse stock split effective June 26, 2025.

  • Compliance with Nasdaq Requirements: The reverse stock split is intended to help the company regain compliance with Nasdaq's continued listing requirements.

[object Object]
Preview
2.0
06-24TipRanks
3 Penny Stocks to Watch Now, 6/24/25

  • Penny Stocks to Watch: Indonesia Energy, Indaptus Therapeutics, and OceanPal Inc. are highlighted as penny stocks to monitor on June 24, 2025, based on their high Dollar Volume and market activity, with each company experiencing significant stock price changes.

  • Market Trends and Events: Indonesia Energy faced volatility due to global oil supply concerns, Indaptus Therapeutics saw a surge linked to an upcoming shareholder meeting, and OceanPal's stock rose after a public offering announcement despite initial negative reactions.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Indaptus Therapeutics Inc (INDP) stock price today?

The current price of INDP is 2.14 USD — it has decreased -0.93 % in the last trading day.

arrow icon

What is Indaptus Therapeutics Inc (INDP)'s business?

Indaptus Therapeutics, Inc. is a clinical-stage biotechnology company, which specializes in cancer and viral infection treatments. The Company’s approach is based on the hypothesis that activation of both innate and adaptive immune cells and pathways and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system-activating signals that can be administered safely intravenously (i.v.). Its technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria producing a multiple Toll-like receptor (TLR), Nucleotide oligomerization domain (NOD)-like receptor (NLR) and Stimulator of interferon genes (STING) agonist Decoy platform. The Company's lead clinical candidate is Decoy20. Its Decoy product candidates have also produced significant single agent activity against chronic hepatitis B virus (HBV) and chronic human immunodeficiency virus (HIV) infections in pre-clinical models.

arrow icon

What is the price predicton of INDP Stock?

Wall Street analysts forecast INDP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INDP is 10.00 USD with a low forecast of 10.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Indaptus Therapeutics Inc (INDP)'s revenue for the last quarter?

Indaptus Therapeutics Inc revenue for the last quarter amounts to -2.65M USD, decreased -15.71 % YoY.

arrow icon

What is Indaptus Therapeutics Inc (INDP)'s earnings per share (EPS) for the last quarter?

Indaptus Therapeutics Inc. EPS for the last quarter amounts to USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for Indaptus Therapeutics Inc (INDP)'s fundamentals?

The market is revising No Change the revenue expectations for Indaptus Therapeutics, Inc. (INDP) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -35.21%.
arrow icon

How many employees does Indaptus Therapeutics Inc (INDP). have?

Indaptus Therapeutics Inc (INDP) has 7 emplpoyees as of December 05 2025.

arrow icon

What is Indaptus Therapeutics Inc (INDP) market cap?

Today INDP has the market capitalization of 3.75M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free